Clifford Chance

Head of EU Public Policy Gail Orton is joined by Healthcare and Life Sciences partner Dr Gunnar Sachs and lawyer Ann-Cathrin Bergstedt to discuss the developments in legislation for cannabis in medical and consumer products across Europe.

This is currently a hot topic, as there are still misunderstandings among national administrations and market players, with the legalization of the drug for recreational use commonly confused with the need to provide safe and legal access to cannabis for medical purposes.

To shed light on the matter, the conversation explores the use of cannabis in medicinal and consumer products across Europe and in Germany. It also focuses on future demand for these products and the direction the respective regulation is likely to take.

The content of this podcast does not constitute legal advice and should not be relied upon as such. Specific legal advice about your specific circumstances should always be sought separately before taking any action.